- Home
- BON vs NCEL Comparison
BON vs NCEL Comparison
Compare BON & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BON | NCEL |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | China | Switzerland |
| Employees | N/A | 11 |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9M | 13.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BON | NCEL |
|---|---|---|
| Price | $1.48 | $2.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 48.4K | 19.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $390.73 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $1.89 |
| 52 Week High | $3.39 | $4.70 |
Technical Indicators
Market Signals| Indicator | BON | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 52.39 |
| Support Level | $1.44 | $2.63 |
| Resistance Level | $1.58 | $3.19 |
| Average True Range (ATR) | 0.11 | 0.16 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 38.80 | 47.17 |
Price Performance
Historical ComparisonAbout BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.
About NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.